
Trump’s social media order, UK opens door to Hong Kong residents, AstraZeneca’s transformation
FT News Briefing
00:00
AstraZeneca's Evolution: From Commercial Tactics to Scientific Leadership
This chapter explores AstraZeneca's evolution from a criticized commercial entity to a leader in pharmaceutical innovation, driven by a focus on research and development. It highlights key changes in drug strategy and the pivotal COVID-19 vaccine collaboration with Oxford University, marking a remarkable turnaround for the company.
Play episode from 06:35
Transcript


